NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/1/2026

1. MU
2. SPY
3. REGN
4. PSKY
5. NKE
6. AMZN
7. WBD
8. GOOGL
9. OXY
10. ACN

Go back to NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA
Asianada, Inc. (NASDAQ: ASND) Delayed: 227.31 -0.52 (0.23%)
Previous Close $227.83    52 Week High $21.79 
Open $228.03    52 Week Low $11.92 
Day High $229.88    P/E N/A 
Day Low $226.00    EPS $-0.07 
Volume 805,982